 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| |
 |
| |
|
|
 |
| |
 |
|
|
 |
| |
 |
|
|
| |
|
|
|
|
|
|
 |
 |
 |
Press Releases
All Releases
 |
/C O R R E C T I O N -- Benda Pharmaceutical, Inc./
Nov 20, 2008
|
27.6 KB |
|
| |
HUBEI PROVINCE, China, Nov 18, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- In the news release, "Benda Pharmaceutical Reports Third Quarter 2008
Financial Results", issued on Nov. 18 by Benda Pharmaceutical, Inc. over PR
Newswire, we are advised by the company that the second last sentence of the
third paragraph under the section, "Ni...
|
 |
Benda Pharmaceutical Reports Third Quarter 2008 Financial Results
Nov 18, 2008
|
27.0 KB |
|
| |
HUBEI PROVINCE, China, Nov. 18 /PRNewswire-FirstCall/ --
Benda Pharmaceutical, Inc. (OTC Bulletin Board: BPMA - News), a China-based
pharmaceutical company producing both Gendicine®, a commercialized gene
therapy medicine for the treatment of cancer, and traditional Chinese and
conventional medicines, today announced finan...
|
 |
Benda Pharmaceutical Files Form 12b-25 for 3Q08 10Q Filing Extension
Nov 14, 2008
|
16.9 KB |
|
| |
HUBEI PROVINCE, China, Nov. 14 /Xinhua-PRNewswire-FirstCall/ -- Benda Pharmaceutical, Inc. (OTC Bulletin Board: BPMA - News), a China-based pharmaceutical company producing both Gendicine®, a commercialized gene therapy medicine for the treatment of cancer, and traditional Chinese and conventional medicines, today announced that it has filed a Form...
|
 |
Benda Pharmaceutical Appoints Chief Operating Officer
Aug 18, 2008
|
18.0 KB |
|
| |
HUBEI, China, Aug 18, 2008 /Xinhua-PRNewswire-FirstCall via COMTEX News Network/ -- Benda Pharmaceutical, Inc. (OTC Bulletin Board: BPMA), a China-based pharmaceutical company producing both Gendicine(R), a commercialized gene therapy medicine for the treatment of cancer, and traditional Chinese and conventional medicines, today announced that it a...
|
 |
Benda Pharmaceutical Reports Second Quarter 2008 Financial Results
Aug 14, 2008
|
28.1 KB |
|
| |
HUBEI PROVINCE, China, Aug 14, 2008 /Xinhua-PRNewswire-FirstCall via COMTEX News Network/ -- Benda Pharmaceutical, Inc. (OTC Bulletin Board: BPMA), a China-based pharmaceutical company producing both Gendicine(R), a commercialized gene therapy medicine for the treatment of cancer, and traditional Chinese and conventional medicines, today announced ...
|
 |
Benda Pharmaceutical Announces Resignation of Board Member
Jun 19, 2008
|
17.5 KB |
|
| |
HUBEI PROVINCE, China, June 19, 2008 /Xinhua-PRNewswire-FirstCall via COMTEX News Network/ -- Benda Pharmaceutical, Inc. (OTC Bulletin Board: BPMA), a China-based pharmaceutical company producing both Gendicine(R), a commercialized gene therapy medicine for the treatment of cancer, and traditional Chinese and conventional medicines, today announced...
|
 |
Benda Pharmaceutical Reports First Quarter 2008 Financial Results
May 21, 2008
|
23.8 KB |
|
| |
HUBEI PROVINCE, China, May 21, 2008 /Xinhua-PRNewswire-FirstCall via COMTEX News Network/ -- Benda Pharmaceutical, Inc. (OTC Bulletin Board: BPMA), a China-based pharmaceutical company producing both Gendicine(R), a commercialized gene therapy medicine for the treatment of cancer, and traditional Chinese and conventional medicines, today announced ...
|
 |
Benda Pharmaceutical Jiangling Plant Awarded GMP Certificate for the Production of Ribavrin
May 13, 2008
|
19.2 KB |
|
| |
HUBEI PROVINCE, China, May 13, 2008 /Xinhua-PRNewswire-FirstCall via COMTEX News Network/ -- Benda Pharmaceutical, Inc. (OTC Bulletin Board: BPMA), a China-based pharmaceutical company producing both Gendicine(R), a commercialized gene therapy medicine for the treatment of cancer, and traditional Chinese and conventional medicines, today announced ...
|
 |
Benda Pharmaceutical Appoints Jun Tang to Board of Directors
May 12, 2008
|
19.1 KB |
|
| |
HUBEI PROVINCE, China, May 12, 2008 /Xinhua-PRNewswire-FirstCall via COMTEX News Network/ -- Benda Pharmaceutical, Inc. (OTC Bulletin Board: BPMA), a China-based pharmaceutical company producing both Gendicine(R), a commercialized gene therapy medicine for the treatment of cancer, and traditional Chinese and conventional medicines, today announced ...
|
 |
Benda Pharmaceutical Files Amendment To Form S-1
May 6, 2008
|
17.1 KB |
|
| |
WUHAN, Hubei, China, May 6, 2008 /Xinhua-PRNewswire-FirstCall via COMTEX News Network/ -- Benda Pharmaceutical, Inc. (OTC Bulletin Board: BPMA), a China-based pharmaceutical company producing both Gendicine®, a commercialized gene therapy medicine for the treatment of cancer, and traditional Chinese and convent...
|
 |
Benda Pharmaceutical Reports Fourth Quarter and Full Year 2007 Financial Results
Mar 31, 2008
|
25.9 KB |
|
| |
HUBEI PROVINCE, China, March 31, 2008 /Xinhua-PRNewswire-FirstCall via COMTEX News Network/ -- Benda Pharmaceutical, Inc. (OTC Bulletin Board: BPMA), a China-based pharmaceutical company producing both Gendicine®, a commercialized gene therapy medicine for the treatment of cancer, and traditional Chinese and co...
|
 |
China-AsiaStocks.com Reports on Healthcare Opportunities in China; Western and Traditional Medicine
Feb 4, 2008
|
21.3 KB |
|
| |
POINT ROBERTS, WA and DELTA, BC, Feb 04, 2008 (MARKET WIRE via COMTEX News Network) -- China-AsiaStocks.com, an investor and industry portal focused on the China-Asia sector within InvestorIdeas.com, reports on the growing Chinese healthcare market opportunities, with focus on featured company, Benda Pharmaceutical Inc.(OTCBB: BPMA). The globalizat...
|
 |
New Benda Investor Video Brings the Gendicine(R) Investment Opportunity to Life
Jan 25, 2008
|
20.3 KB |
|
| |
HUBEI PROVINCE, China, Jan 25, 2008 (BUSINESS WIRE) -- Benda Pharmaceutical, Inc. ("Benda" or the "Company") (OTCBB:BPMA), a China-based pharmaceutical company producing both Gendicine(R), the world's first commercialized gene therapy medicine for the treatment of cancer, and traditional Chinese and conventional medicines, announced today that it h...
|
 |
Benda Updates $3.8 MM Gendicine(R) Order Status - Revenue Realization Ahead of Schedule
Jan 23, 2008
|
19.7 KB |
|
| |
HUBEI PROVINCE, China, Jan 23, 2008 (BUSINESS WIRE) -- Benda Pharmaceutical, Inc. ("Benda" or the "Company") (OTC BB: BPMA), a China-based pharmaceutical company producing both Gendicine(R), the world's first commercialized gene therapy medicine for the treatment of cancer, and traditional Chinese and conventional medicines, announced today it real...
|
 |
Benda's Jiangling Plant Receives Production Approval
Jan 22, 2008
|
14.0 KB |
|
| |
HUBEI PROVINCE, China, Jan 22, 2008 (BUSINESS WIRE) -- Benda Pharmaceutical, Inc. ("Benda" or the "Company") (OTCBB: BPMA), a China-based pharmaceutical company producing both Gendicine(R), the world's first commercialized gene therapy medicine for the treatment of cancer, and traditional Chinese and conventional medicines, announced today that its...
|
 |
Benda Enters Into Complementary Financial Advisory Agreements with CRT Capital Group LLC and EastGate Financial, Inc.
Jan 11, 2008
|
21.2 KB |
|
| |
HUBEI PROVINCE, China, Jan 11, 2008 (BUSINESS WIRE) -- Benda Pharmaceutical, Inc. ("Benda" or the "Company") (OTCBB: BPMA), a China-based pharmaceutical company producing traditional Chinese and conventional medicines, as well as Gendicine(R), the world's first commercialized gene therapy medicine for the treatment of cancer, announced today that i...
|
 |
Benda Dramatically Expands Largest Plant's Capacity and Product Mix; First of Five New Products Expected to Add $1.8 MM to 2008 Revenue
Jan 11, 2008
|
20.8 KB |
|
| |
HUBEI PROVINCE, China, Jan 11, 2008 (BUSINESS WIRE) -- Benda Pharmaceutical, Inc. ("Benda" or the "Company") (OTCBB:BPMA), a China-based pharmaceutical company producing traditional Chinese and conventional medicines, as well as Gendicine(R), the world's first commercialized gene therapy medicine for the treatment of cancer, announced today that it...
|
 |
Benda Reports on $3.8 MM Gendicine(R) Order Status and Provides Production Capacity Update
Dec 5, 2007
|
20.5 KB |
|
| |
HUBEI PROVINCE, China, Dec 05, 2007 (BUSINESS WIRE) -- Benda Pharmaceutical, Inc. ("Benda" or the "Company") (OTCBB: BPMA), a China-based pharmaceutical company producing traditional Chinese and conventional medicines, as well as Gendicine(R), the world's first commercialized gene therapy medicine for the treatment of cancer, announced today that i...
|
 |
Benda November 28, 2007, Earnings Conference Call Reminder and Dial in Number Correction
Nov 27, 2007
|
20.6 KB |
|
| |
HUBEI PROVINCE, China, Nov 27, 2007 (BUSINESS WIRE) -- Benda Pharmaceutical, Inc. ("Benda" or the "Company") (OTCBB:BPMA), a China-based pharmaceutical company producing traditional Chinese and conventional medicines, as well as Gendicine(R), the world's first commercialized gene therapy medicine for the treatment of cancer, will host a conference ...
|
 |
Benda Revenue Up 61% to $7.6 Million for Quarter Ended September 30, 2007
Nov 20, 2007
|
22.6 KB |
|
| |
HUBEI PROVINCE, CHINA, Nov 20, 2007 (MARKET WIRE via COMTEX News Network) -- Benda Pharmaceutical, Inc. ("Benda" or the "Company") (OTCBB: BPMA), a China-based pharmaceutical company producing traditional Chinese and conventional medicines, as well as Gendicine(R), the world's first commercialized gene therapy medicine for the treatment of cancer, ...
|
|
|
 = add release to Briefcase
| |
 |
 |
 |
 |
 |
| |
 |
| |
 |
 |
 |
| |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
| |
|
 |
|
|
 |